Growth Metrics

Biote (BTMD) Accumulated Expenses (2021 - 2025)

Biote has reported Accumulated Expenses over the past 5 years, most recently at $5.8 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $5.8 million for Q4 2025, down 48.54% from a year ago — trailing twelve months through Dec 2025 was $5.8 million (down 48.54% YoY), and the annual figure for FY2025 was $5.8 million, down 48.54%.
  • Accumulated Expenses for Q4 2025 was $5.8 million at Biote, down from $11.1 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for BTMD hit a ceiling of $11.3 million in Q4 2024 and a floor of $4000.0 in Q3 2021.
  • Median Accumulated Expenses over the past 5 years was $6.1 million (2023), compared with a mean of $5.8 million.
  • Biggest five-year swings in Accumulated Expenses: soared 18670.37% in 2024 and later plummeted 48.54% in 2025.
  • Biote's Accumulated Expenses stood at $2.2 million in 2021, then soared by 183.51% to $6.3 million in 2022, then decreased by 3.28% to $6.1 million in 2023, then skyrocketed by 86.11% to $11.3 million in 2024, then crashed by 48.54% to $5.8 million in 2025.
  • The last three reported values for Accumulated Expenses were $5.8 million (Q4 2025), $11.1 million (Q3 2025), and $9.0 million (Q2 2025) per Business Quant data.